TdT anticorps (N-Term) (FITC)
Aperçu rapide pour TdT anticorps (N-Term) (FITC) (ABIN294481)
Antigène
Voir toutes TdT (DNTT) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- N-Term
-
Specificité
- Is a mixture of 3 monoclonal antibodies specific for human terminal deoxynucleotidyl transferase (TdT). TdT is a DNA polymerase responsible for the catalysis of non-reversible addition of deoxynucleotides to the 3 end hydroxy groups of DNA. TdT levels are enhanced in all forms of acute lymphoblastic leukaemia (ALL) and in a significant number of chronic lymphoblastic leukaemia cases (CML). TdT is not expressed in the majority of myeloid leukemias, non-Hodgkins lymphomas or mature lymphoid leukemias.
-
Purification
- Purified
-
Immunogène
-
Type of Immunogen: Native protein
-
-
-
-
Indications d'application
-
Approved: Flo (1:1)
Usage: Flow Cytometry: Use 10 μL of the suggested working dilution to label 1x10^6 cells in 100 μL. Membrane permeabilization is required for this application. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide, 1 % BSA.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
-
Autre désignation
- DNTT / TdT
-
Sujet
-
Name/Gene ID: DNTT
Synonyms: DNTT, DNA nucleotidylexotransferase, TDT, Terminal addition enzyme, Terminal transferase -
ID gène
- 1791
-
Pathways
- Réparation de l'ADN
Antigène
-